| 1 | | | | | | | | 2 | 0.78% |
| 2 | ryvlin and the organizing | | | | | | | 1 | 0.39% |
| 3 | look very much forward | | | | | | | 1 | 0.39% |
| 4 | very much forward to | | | | | | | 1 | 0.39% |
| 5 | much forward to welcoming | | | | | | | 1 | 0.39% |
| 6 | forward to welcoming you | | | | | | | 1 | 0.39% |
| 7 | to welcoming you in | | | | | | | 1 | 0.39% |
| 8 | the olympic capital professor | | | | | | | 1 | 0.39% |
| 9 | olympic capital professor philippe | | | | | | | 1 | 0.39% |
| 10 | professor philippe ryvlin | | | | | | | 1 | 0.39% |
| 11 | professor philippe ryvlin and | | | | | | | 1 | 0.39% |
| 12 | philippe ryvlin and the | | | | | | | 1 | 0.39% |
| 13 | committee | | | | | | | 1 | 0.39% |
| 14 | more we look very | | | | | | | 1 | 0.39% |
| 15 | endorsed | | | | | | | 1 | 0.39% |
| 16 | endorsed by | | | | | | | 1 | 0.39% |
| 17 | endorsed by the | | | | | | | 1 | 0.39% |
| 18 | endorsed by the european | | | | | | | 1 | 0.39% |
| 19 | by the european reference | | | | | | | 1 | 0.39% |
| 20 | the european reference network | | | | | | | 1 | 0.39% |
| 21 | european reference network for | | | | | | | 1 | 0.39% |
| 22 | reference network for rare | | | | | | | 1 | 0.39% |
| 23 | and complex epilepsies ern | | | | | | | 1 | 0.39% |
| 24 | complex epilepsies ern epicare | | | | | | | 1 | 0.39% |
| 25 | epilepsies ern epicare | | | | | | | 1 | 0.39% |
| 26 | we look very much | | | | | | | 1 | 0.39% |
| 27 | and more we look | | | | | | | 1 | 0.39% |
| 28 | epicare | | | | | | | 1 | 0.39% |
| 29 | management of epilepsy comorbidities | | | | | | | 1 | 0.39% |
| 30 | mri interpretation communication with | | | | | | | 1 | 0.39% |
| 31 | interpretation communication with patients | | | | | | | 1 | 0.39% |
| 32 | communication with patients and | | | | | | | 1 | 0.39% |
| 33 | caregivers management of seizure | | | | | | | 1 | 0.39% |
| 34 | management of seizure clusters | | | | | | | 1 | 0.39% |
| 35 | of seizure clusters and | | | | | | | 1 | 0.39% |
| 36 | seizure clusters and status | | | | | | | 1 | 0.39% |
| 37 | clusters and status epileptics | | | | | | | 1 | 0.39% |
| 38 | prevention and management of | | | | | | | 1 | 0.39% |
| 39 | and management of epilepsy | | | | | | | 1 | 0.39% |
| 40 | home registration to register | | | | | | | 1 | 0.39% |